. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: J Neuroimmune Pharmacol. 2018 Jul 6;14(1):120–133. doi: 10.1007/s11481-018-9792-7

Table 1.

Demographic and clinical characteristics

MHBB cohort characteristics	Overall (N = 45) Median [IQR] or n (%)

Age (yr)	56 [47, 65]
Gender
Female	24 (53.3%)
Male	21 (46.7%)
Race
Black	18 (40.0%)
Hispanic	18 (40.0%)
White	9 (20.0%)
Years from HIV diagnosis	21 [3, 30]

Years from starting cART	15 [0, 24]

Years between HIV diagnosis and starting cART	4 [0 , 23]
HAND	21 (46.7%)
CD4 T cell count (cells/mm³)	475 [0, 989]
Nadir CD4 T cell count (cells/mm³)	67 [0, 261]
Plasma HIV RNA (log₁₀ copies/ml)	1.4 [1.4, 2.1]
Viral load undetectable (<20 copies/ml)	19 (42.2%)
Viral load >20 - <400 copies/ml	20 (44.4%)
Viral load >400 copies/ml	6 (13.3%)